180 related articles for article (PubMed ID: 6584876)
1. Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
Sundberg EE; Illingworth DR
Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7631-5. PubMed ID: 6584876
[TBL] [Abstract][Full Text] [Related]
2. Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.
Illingworth DR
Ann Intern Med; 1984 Nov; 101(5):598-604. PubMed ID: 6567462
[TBL] [Abstract][Full Text] [Related]
3. Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.
Kane JP; Malloy MJ; Tun P; Phillips NR; Freedman DD; Williams ML; Rowe JS; Havel RJ
N Engl J Med; 1981 Jan; 304(5):251-8. PubMed ID: 7003391
[TBL] [Abstract][Full Text] [Related]
4. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
5. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
[TBL] [Abstract][Full Text] [Related]
6. The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia.
Hagemenas FC; Pappu AS; Illingworth DR
Eur J Clin Invest; 1990 Apr; 20(2):150-7. PubMed ID: 2112479
[TBL] [Abstract][Full Text] [Related]
7. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia.
Illingworth DR; Phillipson BE; Rapp JH; Connor WE
Lancet; 1981 Feb; 1(8215):296-8. PubMed ID: 6109940
[TBL] [Abstract][Full Text] [Related]
8. Familial type II hyperlipoproteinemia with coronary heart disease: effect of diet-colestipol-nicotinic acid treatment.
Kuo PT; Kostis JB; Moreyra AE; Hayes JA
Chest; 1981 Mar; 79(3):286-91. PubMed ID: 7471860
[TBL] [Abstract][Full Text] [Related]
9. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
[TBL] [Abstract][Full Text] [Related]
10. Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholesterolemia.
Grundy SM; Vega GL; Bilheimer DW
Ann Intern Med; 1985 Sep; 103(3):339-43. PubMed ID: 3849281
[TBL] [Abstract][Full Text] [Related]
11. Pediatric familial type II hyperlipoproteinemia: therapy with diet and colestipol resin.
Glueck CJ; Fallat RW; Mellies M; Tsang RC
Pediatrics; 1976 Jan; 57(1):68-74. PubMed ID: 174057
[TBL] [Abstract][Full Text] [Related]
12. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
[TBL] [Abstract][Full Text] [Related]
13. Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
Glueck CJ
Ann Intern Med; 1982 Apr; 96(4):475-82. PubMed ID: 7039445
[TBL] [Abstract][Full Text] [Related]
14. Combination drug therapy for familial combined hyperlipidemia.
East C; Bilheimer DW; Grundy SM
Ann Intern Med; 1988 Jul; 109(1):25-32. PubMed ID: 3288029
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol homeostasis in mononuclear leukocytes from patients with familial hypercholesterolemia treated with lovastatin.
Hagemenas FC; Illingworth DR
Arteriosclerosis; 1989; 9(3):355-61. PubMed ID: 2719596
[TBL] [Abstract][Full Text] [Related]
16. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Crouse JR; Grundy SM
Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
[TBL] [Abstract][Full Text] [Related]
17. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
[TBL] [Abstract][Full Text] [Related]
18. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
Illingworth DR; Bacon S
Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
[TBL] [Abstract][Full Text] [Related]
19. "Low dose" colestipol in children, adolescents and young adults with familial hypercholesterolemia.
Schlierf G; Mrozik K; Heuck CC; Middelhoff G; Oster P; Riesen W; Schellenberg B
Atherosclerosis; 1982 Jan; 41(1):133-8. PubMed ID: 7073790
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate and colestipol: effects on serum and lipoprotein lipids and apolipoproteins in familial hypercholesterolaemia.
Weisweiler P; Merk W; Jacob B; Schwandt P
Eur J Clin Pharmacol; 1986; 30(2):191-4. PubMed ID: 3709644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
